Anixa Biosciences (ANIX) Cash & Current Investments (2010 - 2026)
Anixa Biosciences' Cash & Current Investments was $13.86 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), down 13.5% from $16.03 million a year earlier but up 1.3% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Cash & Current Investments at Anixa Biosciences came in at $15.17 million, down 23.8% from FY2024.
- Cash & Current Investments has now declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- In earlier fiscal years, Cash & Current Investments was $19.92 million in FY2024 (-16.4%), $23.84 million in FY2023 (-19.7%), $29.69 million in FY2022 (-16.9%) and $35.73 million in FY2021 (+294.5%).
- Quarterly Cash & Current Investments has moved between $13.69 million (fiscal Q2 2026) and $35.73 million (fiscal Q4 2021) over five years.
- The best year-over-year quarter for Cash & Current Investments over five years was fiscal Q4 2021 (growth of 294.5%); the worst was fiscal Q2 2025 (a decline of 32.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Anixa Biosciences | 101.52 Mn | 87.66 Mn | - | 13.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 13.86 Mn |
| Apr 30, 2026 | 13.69 Mn |
| Oct 31, 2025 | 15.17 Mn |
| Jul 31, 2025 | 16.03 Mn |
| Apr 30, 2025 | 15.60 Mn |
| Jan 31, 2025 | 17.26 Mn |
| Oct 31, 2024 | 19.92 Mn |
| Jul 31, 2024 | 20.75 Mn |
| Apr 30, 2024 | 23.24 Mn |
| Jan 31, 2024 | 23.80 Mn |
| Oct 31, 2023 | 23.84 Mn |
| Jul 31, 2023 | 25.53 Mn |
| Apr 30, 2023 | 26.98 Mn |
| Jan 31, 2023 | 27.70 Mn |
| Oct 31, 2022 | 29.69 Mn |
| Jul 31, 2022 | 31.66 Mn |
| Apr 30, 2022 | 32.23 Mn |
| Jan 31, 2022 | 34.53 Mn |
| Oct 31, 2021 | 35.73 Mn |
| Jul 31, 2021 | 36.62 Mn |
API Access
Anixa Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();